CN104888201B - 用于防治糖尿病及其慢性并发症的肽类药物 - Google Patents
用于防治糖尿病及其慢性并发症的肽类药物 Download PDFInfo
- Publication number
- CN104888201B CN104888201B CN201510366482.7A CN201510366482A CN104888201B CN 104888201 B CN104888201 B CN 104888201B CN 201510366482 A CN201510366482 A CN 201510366482A CN 104888201 B CN104888201 B CN 104888201B
- Authority
- CN
- China
- Prior art keywords
- peptide
- diabetes
- peptides
- complicating diseases
- terminal fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510366482.7A CN104888201B (zh) | 2015-06-29 | 2015-06-29 | 用于防治糖尿病及其慢性并发症的肽类药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510366482.7A CN104888201B (zh) | 2015-06-29 | 2015-06-29 | 用于防治糖尿病及其慢性并发症的肽类药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104888201A CN104888201A (zh) | 2015-09-09 |
CN104888201B true CN104888201B (zh) | 2018-04-27 |
Family
ID=54021440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510366482.7A Active CN104888201B (zh) | 2015-06-29 | 2015-06-29 | 用于防治糖尿病及其慢性并发症的肽类药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104888201B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE520392C2 (sv) * | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
GB0218970D0 (en) * | 2002-08-14 | 2002-09-25 | Creative Peptides Sweden Ab | Fragments of Insulin c-peptide |
-
2015
- 2015-06-29 CN CN201510366482.7A patent/CN104888201B/zh active Active
Non-Patent Citations (2)
Title |
---|
role of C-peptide in human physiology;John Wahren等;《am j physiol endocrinol metab》;20001231;摘要 * |
the clinical ppotential of C-peptide replacement in type 1 diabetes;John Wahren等;《diabetes》;20120430;761-772 * |
Also Published As
Publication number | Publication date |
---|---|
CN104888201A (zh) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2206721A1 (en) | Neuromedin u derivative | |
CN101095942B (zh) | 一种包含稳定剂的Exendin-4注射剂药物配方 | |
KR20130043085A (ko) | 가용성 및 결정 형태의 지속형 인슐린 유사체 제제 | |
CN103450345A (zh) | Vip片段和应用方法 | |
CN105188736A (zh) | 胰岛素给药方案 | |
CN107375910B (zh) | PTHrP在制备治疗男性性腺功能低下综合征中的应用 | |
US20240108585A1 (en) | Compositions comprising lipid-based nanoparticles for treating diabetes mellitus | |
CN108025060A (zh) | 使用胰高血糖素受体拮抗性抗体治疗1型糖尿病的方法 | |
CN106977593A (zh) | 多胜肽、编码该多胜肽的核酸分子、以及该多胜肽的应用 | |
CN107213149A (zh) | 青蒿素类衍生物在制备治疗或辅助治疗自身免疫性甲状腺疾病药物中的用途 | |
CN109069595A (zh) | 标靶医疗性溶酶体酵素融合蛋白质、其相关调配物与用途 | |
CN110302362B (zh) | 一种蛋白在制备预防和治疗糖尿病并发症的药物中的应用 | |
CN102302510B (zh) | 一种药物组合物及其用途 | |
JP2024003211A (ja) | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 | |
CN104888201B (zh) | 用于防治糖尿病及其慢性并发症的肽类药物 | |
EP3883960A1 (en) | Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intake | |
EP3718552A1 (en) | Combination drug suitable for treatment and prevention of non-alcoholic fatty liver disease (naflad) and/or non-alcoholic steatohepatitis (nash), and/or hepatic steatosis | |
CN110038114A (zh) | 一种多肽在制备预防或治疗代谢综合征药物中的用途 | |
CN105792839A (zh) | 用于治疗的胰岛素样生长因子拟似物 | |
CA3011062A1 (en) | Pharmaceutical formulations for the treatment of diabetes | |
EP3653639B1 (en) | Polypeptide and composition thereof for treating diseases of metabolic system | |
CN103402534B (zh) | 用于治疗充血性心力衰竭的治疗方法 | |
JP2002522507A (ja) | 疾患状態の処置 | |
JPH06510753A (ja) | インスリン欠乏哺乳動物治療用のインスリンおよびアミリンを含有する組成物 | |
JPWO2020082950A5 (zh) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Qi Jinsheng Inventor after: Li Yanning Inventor after: He Kunyu Inventor after: Liu Daimeng Inventor after: He Zhi Inventor before: Qi Jinsheng Inventor before: Li Yanning Inventor before: Wang Xiujuan Inventor before: Liu Kun Inventor before: Li Bin |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200424 Address after: No.1608, building 1, science and technology center, No.136, Huanghe Avenue, hi tech Zone, Shijiazhuang City, Hebei Province Patentee after: Zhukang Biotechnology Co., Ltd Address before: 503, No. 5, unit 24, building 12, Yuejin Road, Shijiazhuang, Hebei, Changan District 050011 Patentee before: Qi Jinsheng |